Age-related changes in mutagen activation by rat tissues

Area of Science:

• Toxicology
• Pharmacology
• Gerontology

Background:

• Drug metabolism efficiency changes with age.
• Liver, lung, and kidney functions are crucial for drug detoxification.
• Understanding age-related metabolic shifts is vital for drug safety.

Purpose of the Study:

• To investigate age-related changes in drug-metabolizing enzymes.
• To assess the impact of aging on the activation of specific promutagens.
• To differentiate between maturation and senescence effects on metabolism.

Main Methods:

• Utilized adult female Long-Evans rats aged 2.5 to 25 months.
• Measured mutagen formation from aflatoxin B1, 2-aminofluorene, and 2-acetylaminofluorene.
• Employed the Ames Salmonella test system with liver, lung, and kidney tissue fractions.

Main Results:

• Hepatic, renal, and pulmonary activation of all tested promutagens decreased with age.
• The most significant decline in mutagen activation occurred before middle age (9-13 months).
• Pulmonary metabolism slightly increased in the oldest rats compared to middle-aged ones.

Conclusions:

• Reduced mutagen activation in aging rats suggests a decline in drug-metabolizing capacity.
• The primary decrease in metabolic activation appears linked to maturation rather than late-life senescence.
• These findings have implications for age-specific drug efficacy and toxicity studies.